Trials / Completed
CompletedNCT01113853
Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients
Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients Stopping Anti-inflammatory Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Universita di Verona · Academic / Other
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
Previous studies have demonstrated that exhaled nitric oxide can be useful to monitor the efficacy of anti-inflammatory treatment as well as to predict a risk of asthma relapse in asthmatic patients. The aim of the present study is to evaluate the time course of exhaled nitric oxide in mild asthmatic patients, stopping regular treatment with inhaled corticosteroids, if it is possible, in relationship with symptoms and lung function.
Detailed description
All patients were evaluated with pulmonary lung function, exhaled nitric oxide and peak expiratory flow (PEF) and fill in a personal diary for the first two weeks when patients are in treatment; the same evaluation will be made for other four weeks without treatment.
Conditions
Timeline
- Start date
- 2007-01-01
- Completion
- 2010-01-01
- First posted
- 2010-04-30
- Last updated
- 2010-05-03
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01113853. Inclusion in this directory is not an endorsement.